Day One Biopharmaceuticals

Corporate brand

Day One Biopharmaceuticals is a United States oncology company, part of Servier, developing targeted cancer therapies for patients of all ages.

Last updated September 15, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Day One Biopharmaceuticals is an oncology-focused company based in Brisbane, California, United States, and is part of Servier. Its team of oncologists, scientists, professionals and business leaders describes a "search & development" strategy aimed at getting better, targeted medicines faster to patients of all ages who urgently need new options. The company pursues pediatric and adult medicine development for areas of unmet need, and works with a network of oncologists, families, scientists and companies to identify and acquire emerging treatments that it then develops and scales for market.

History

Day One Biopharmaceuticals is part of Servier. Its team of oncologists, scientists, professionals and business leaders describes itself as unafraid to disrupt the status quo of traditional drug development in order to get better, targeted medicines faster to patients of all ages who urgently need new options. The company follows a "search & development" strategy that guides it to the right programs for the right patients, and it works with a network of oncologists, families, scientists and companies to identify and acquire emerging treatments, which it then develops and scales for market. Day One's newsroom records that on 03/06/2026 Servier and Day One Biopharmaceuticals announced an acquisition to expand Servier's rare oncology portfolio, and that on 02/24/2026 Day One reported fourth quarter and full year 2025 financial results and reaffirmed its 2026 outlook and revenue guidance.

Products and positioning

Oncology company pursuing a "search & development" strategy to deliver targeted medicines faster to patients of all ages with serious diseases.

Recent events

2021.08.17
Reported2021.08.17
Day One appoints Scott Garland to its board[6]Day One任命Scott Garland加入董事会biospace.com
Day One Biopharmaceuticals announced the appointment of Scott Garland to its board of directors.

Sources6 sources

Cite this profile: Cite the canonical profile. /brand-wiki/day-one-biopharmaceuticals · Editorial policy · How profiles are compiled